INS and Alzheimer disease: This finding aligns with observed changes in the levels of insulin signaling molecules in the brains of AD patients, as well as improvements in memory following intranasal insulin administration in such cases (Claxton et al. 2015; McClure Yauch et al. 2022; Wong et al. 2024).